Ming‐Ching Kao

2.5k total citations
72 papers, 2.1k citations indexed

About

Ming‐Ching Kao is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Ming‐Ching Kao has authored 72 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 19 papers in Pharmacology and 17 papers in Oncology. Recurrent topics in Ming‐Ching Kao's work include Natural product bioactivities and synthesis (8 papers), Fungal Biology and Applications (7 papers) and HER2/EGFR in Cancer Research (6 papers). Ming‐Ching Kao is often cited by papers focused on Natural product bioactivities and synthesis (8 papers), Fungal Biology and Applications (7 papers) and HER2/EGFR in Cancer Research (6 papers). Ming‐Ching Kao collaborates with scholars based in Taiwan, United States and Japan. Ming‐Ching Kao's co-authors include Tzong‐Der Way, Jen‐Kun Lin, Tzu‐Chao Chuang, Jah‐Yao Liu, Shih‐Chung Hsu, Chih‐Hsin Tang, Vinchi Wang, Huei-Yann Tsai, Rong‐Sen Yang and Yuh‐Fung Chen and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Oncogene.

In The Last Decade

Ming‐Ching Kao

71 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming‐Ching Kao Taiwan 26 1.1k 475 276 243 220 72 2.1k
Guang Xu China 28 1.4k 1.3× 297 0.6× 321 1.2× 295 1.2× 179 0.8× 54 2.5k
Qi Jia China 29 973 0.9× 507 1.1× 297 1.1× 205 0.8× 257 1.2× 146 2.5k
Byoungduck Park South Korea 23 1.2k 1.1× 267 0.6× 321 1.2× 305 1.3× 203 0.9× 57 2.4k
Sunga Choi South Korea 25 1.5k 1.4× 311 0.7× 222 0.8× 180 0.7× 150 0.7× 57 2.2k
Young‐Rae Lee South Korea 27 1.0k 0.9× 247 0.5× 215 0.8× 342 1.4× 171 0.8× 81 2.1k
Dongwoo Nam South Korea 30 1.3k 1.2× 411 0.9× 456 1.7× 343 1.4× 394 1.8× 101 2.7k
Joshua Ka-Shun Ko Hong Kong 29 1.2k 1.1× 298 0.6× 252 0.9× 229 0.9× 409 1.9× 75 2.6k
Byeong‐Churl Jang South Korea 29 1.4k 1.3× 416 0.9× 261 0.9× 363 1.5× 110 0.5× 110 2.7k
Seong‐Il Suh South Korea 29 955 0.9× 345 0.7× 241 0.9× 299 1.2× 97 0.4× 81 2.2k
Li‐Sung Hsu Taiwan 27 991 0.9× 207 0.4× 221 0.8× 244 1.0× 132 0.6× 87 1.9k

Countries citing papers authored by Ming‐Ching Kao

Since Specialization
Citations

This map shows the geographic impact of Ming‐Ching Kao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Ching Kao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Ching Kao more than expected).

Fields of papers citing papers by Ming‐Ching Kao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Ching Kao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Ching Kao. The network helps show where Ming‐Ching Kao may publish in the future.

Co-authorship network of co-authors of Ming‐Ching Kao

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Ching Kao. A scholar is included among the top collaborators of Ming‐Ching Kao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Ching Kao. Ming‐Ching Kao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chuang, Tzu‐Chao, Shih‐Chung Hsu, Yi‐Jen Lee, et al.. (2023). Baicalein suppresses HER2 ‐mediated malignant transformation of HER2 ‐overexpressing ovarian cancer cells by downregulating HER2 gene expression. Environmental Toxicology. 38(7). 1609–1617. 5 indexed citations
2.
3.
Su, Yuan‐Chih, Shen‐Chieh Chou, Wen‐Chao Ho, et al.. (2018). The characteristics and prescription patterns of Chinese herbal medicine in clinical practice for the treatment of anemia. Taiwanese Journal of Obstetrics and Gynecology. 57(4). 570–577. 16 indexed citations
4.
5.
Chang, Kuo‐Wei, Cheng-Chia Yu, Ming‐Ching Kao, et al.. (2015). Hinokitiol suppressed pan-histone expression and cell growth in oral squamous cell carcinoma cells. Journal of Functional Foods. 15. 452–463. 12 indexed citations
6.
Wang, Vinchi, Tzu‐Chao Chuang, Ming‐Ching Kao, et al.. (2013). Polymorphic Ala-allele carriers at residue 1170 of HER2 associated with Parkinson's disease. Journal of the Neurological Sciences. 325(1-2). 115–119. 5 indexed citations
7.
Chang, Chih‐Hsiang, et al.. (2011). Engineering of Escherichia coli for targeted delivery of transgenes to HER2/neu‐positive tumor cells. Biotechnology and Bioengineering. 108(7). 1662–1672. 20 indexed citations
8.
Liao, Ya-Fan, Hui‐Chih Hung, Pei‐Chen Hsu, et al.. (2008). Ornithine decarboxylase interferes with macrophage-like differentiation and matrix metalloproteinase-9 expression by tumor necrosis factor alpha via NF-κB. Leukemia Research. 32(7). 1124–1140. 9 indexed citations
9.
Liu, Jah-Yao, Tzu‐Chao Chuang, Tzong‐Der Way, et al.. (2008). The N-terminal domain of EBNA1 acts as a suppressor of the HER2/neu oncogene. Cancer Letters. 273(2). 273–280. 5 indexed citations
10.
Liao, Ya-Fan, Hui‐Chih Hung, Tzyh‐Chyuan Hour, et al.. (2008). Curcumin induces apoptosis through an ornithine decarboxylase-dependent pathway in human promyelocytic leukemia HL-60 cells. Life Sciences. 82(7-8). 367–375. 41 indexed citations
11.
Hsu, Shih‐Chung, et al.. (2008). Downregulation of HER2 by RIG1 involves the PI3K/Akt pathway in ovarian cancer cells. Carcinogenesis. 29(2). 299–306. 36 indexed citations
12.
Chuang, Tzu‐Chao, et al.. (2007). Human manganese superoxide dismutase suppresses HER2/neu‐mediated breast cancer malignancy. FEBS Letters. 581(23). 4443–4449. 38 indexed citations
13.
Chuang, Tzu‐Chao, et al.. (2005). Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan. International Journal of Oncology. 26(4). 933–43. 10 indexed citations
14.
Wang, Vinchi, Tzu‐Chao Chuang, Yaw‐Don Hsu, Wei‐Yuan Chou, & Ming‐Ching Kao. (2005). Nitric oxide induces prion protein via MEK and p38 MAPK signaling. Biochemical and Biophysical Research Communications. 333(1). 95–100. 20 indexed citations
15.
Way, Tzong‐Der, Ming‐Ching Kao, & Jen‐Kun Lin. (2004). Apigenin Induces Apoptosis through Proteasomal Degradation of HER2/neu in HER2/neu-overexpressing Breast Cancer Cells via the Phosphatidylinositol 3-Kinase/Akt-dependent Pathway. Journal of Biological Chemistry. 279(6). 4479–4489. 202 indexed citations
16.
Chuang, Tzu‐Chao, Yi‐Jen Lee, Jah‐Yao Liu, et al.. (2003). EBNA1 may prolong G2/M phase and sensitize HER2/neu-overexpressing ovarian cancer cells to both topoisomerase II-targeting and paclitaxel drugs. Biochemical and Biophysical Research Communications. 307(3). 653–659. 10 indexed citations
17.
18.
Shyu, Woei‐Cherng, et al.. (2000). Creutzfeldt-Jakob disease: heat shock protein 70 mRNA levels in mononuclear blood cells and clinical study. Journal of Neurology. 247(12). 929–934. 13 indexed citations
19.
Hu, Kuang-Yu, et al.. (1998). Isolation and characterization of a newly identified type II restriction endonuclease from a local streptomyces sp. in Taiwan. Applied Biochemistry and Biotechnology. 73(2-3). 231–241.
20.
Hsu, Yaw‐Don, et al.. (1997). Application of chromosome 4q35-qter marker (pFR-1) for DNA rearrangement of facioscapulohumeral muscular dystrophy patients in Taiwan. Journal of the Neurological Sciences. 149(1). 73–79. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guang Xu Breakdown of academic impact, for papers by Qi Jia Breakdown of academic impact, for papers by Byoungduck Park Breakdown of academic impact, for papers by Sunga Choi Breakdown of academic impact, for papers by Young‐Rae Lee Breakdown of academic impact, for papers by Dongwoo Nam Breakdown of academic impact, for papers by Joshua Ka-Shun Ko Breakdown of academic impact, for papers by Byeong‐Churl Jang Breakdown of academic impact, for papers by Seong‐Il Suh Breakdown of academic impact, for papers by Li‐Sung Hsu
Rankless by CCL
2026